0HQ8 Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 32.88 |
| 52 Week High | SEK 53.70 |
| 52 Week Low | SEK 32.80 |
| Beta | 0.42 |
| 11 Month Change | -10.18% |
| 3 Month Change | -18.17% |
| 1 Year Change | -11.78% |
| 33 Year Change | -71.38% |
| 5 Year Change | -23.50% |
| Change since IPO | 35.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HQ8 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -6.4% | -2.1% | 0.7% |
| 1Y | -11.8% | -4.0% | 6.1% |
Return vs Industry: 0HQ8 underperformed the UK Medical Equipment industry which returned -4% over the past year.
Return vs Market: 0HQ8 underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
| 0HQ8 volatility | |
|---|---|
| 0HQ8 Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HQ8 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HQ8's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 6,500 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| 0HQ8 fundamental statistics | |
|---|---|
| Market cap | SEK 8.94b |
| Earnings (TTM) | SEK 505.00m |
| Revenue (TTM) | SEK 11.18b |
17.7x
P/E Ratio0.8x
P/S RatioIs 0HQ8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HQ8 income statement (TTM) | |
|---|---|
| Revenue | SEK 11.18b |
| Cost of Revenue | SEK 6.31b |
| Gross Profit | SEK 4.87b |
| Other Expenses | SEK 4.37b |
| Earnings | SEK 505.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 1.85 |
| Gross Margin | 43.59% |
| Net Profit Margin | 4.52% |
| Debt/Equity Ratio | 53.3% |
How did 0HQ8 perform over the long term?
See historical performance and comparison